September 9th, 2014

Wockhardt Recalls Blood Pressure Drug

Wockhardt Recalls BP Drug

September 2, 2014

The U.S. Food and Drug Administration (FDA) announced on Friday that Wockhardt has initiated a voluntary recall of its high blood pressure medication.

Wockhardt is pulling more than 11,500 high density polyethylene plastic bottles of metoprolol succinate (Toprol-XL). This is the third recall this year. This most recent recall is due to failing a dissolution test.

In April, the Indian drugmaker recalled more than 100,000 bottles of metoprolol succinate for the same reason.  After the FDA discovered manufacturing violations, two of the company’s manufacturing sites were been banned from exporting to the United States, Reuters reported.

References:

1. Wockhardt Recalls More Than 11,60Wockhardt Recalls More Than 11,600 Bottles of Generic Toprol-XL [press release]. FDANews. 2014 Aug 29.

2. Reuters staff. Wockhardt Recalls over 109,000 Bottles of Hypertension Drug in U.S. Pharmacy Learning Network. 2014 May 15.

3. Kanungo S. Wockhardt recalls same drug for third time in the US since May. dna. www.dnaindia.com. 2014 Sept 1.

PLN Topics:
Cardiology
Medication Errors
RELATED ARTICLES
Compounding Pharmacy Recall
Parkinson’s Drug Recall
Massive Antibiotic Recall
Antibiotic Recall Due to Particulate Matter
Apotex Recalls One Lot of Organ Rejection Drug Due to Label Error